| Dr Christopher William Follansbee, MD | |
|
4401 Penn Ave, Pittsburgh, PA 15224-1334 | |
| (412) 692-8436 | |
| Not Available |
| Full Name | Dr Christopher William Follansbee |
|---|---|
| Gender | Male |
| Speciality | Pediatric Medicine |
| Experience | 13 Years |
| Location | 4401 Penn Ave, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013202910 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD451339 (Pennsylvania) | Secondary |
| 2080P0202X | Pediatrics - Pediatric Cardiology | MD451339 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Pittsburgh Physicians | 8729990239 | 3721 |
News Archive
A pioneering professor and investigator at the forefront of genetic services in the United Kingdom and who helped define rare genetic diseases is the 2010 recipient of the March of Dimes/Colonel Harland Sanders Award for lifetime achievement in the field of genetic sciences.
Virtual reality (VR) has potential to revolutionize some aspects of medicine and healthcare. Several medical specialties are already using it to train physicians and assist diagnosis and it also has potential for treatment. A group of cardiologists has now successfully used a VR device to guide the opening up (revascularization) of a chronically blocked right coronary artery.
Cantrell Drug Company today announced amendment of its U.S. Food and Drug Administration (FDA) registration to include the new 503B "compounding outsourcing facility" designation established under the recently passed Drug Quality and Security Act so that it can continue to serve patients nationwide with sterile medications that meet the most exacting quality standards.
Symbiomix Therapeutics, a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women's health infections, today announced results from its Phase 1 clinical program demonstrating that its lead product candidate, SYM-1219, was safe and well tolerated and had predictable pharmacokinetics (PK), and that contraceptive efficacy for birth control pills would not be altered by SYM-1219 administration.
Venture capitalists and Wall Street have invested millions of dollars to capitalize on the health care industry's burgeoning demand for information technology. But in New York State, the push to automate the Medicaid enrollment process is being led not by a behemoth IT corporation, but by a tiny not-for-profit: the Hudson Center for Health Equity & Quality (Hudson Center). And 2012 is shaping up to be its breakout year.
› Verified 5 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
A pioneering professor and investigator at the forefront of genetic services in the United Kingdom and who helped define rare genetic diseases is the 2010 recipient of the March of Dimes/Colonel Harland Sanders Award for lifetime achievement in the field of genetic sciences.
Virtual reality (VR) has potential to revolutionize some aspects of medicine and healthcare. Several medical specialties are already using it to train physicians and assist diagnosis and it also has potential for treatment. A group of cardiologists has now successfully used a VR device to guide the opening up (revascularization) of a chronically blocked right coronary artery.
Cantrell Drug Company today announced amendment of its U.S. Food and Drug Administration (FDA) registration to include the new 503B "compounding outsourcing facility" designation established under the recently passed Drug Quality and Security Act so that it can continue to serve patients nationwide with sterile medications that meet the most exacting quality standards.
Symbiomix Therapeutics, a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women's health infections, today announced results from its Phase 1 clinical program demonstrating that its lead product candidate, SYM-1219, was safe and well tolerated and had predictable pharmacokinetics (PK), and that contraceptive efficacy for birth control pills would not be altered by SYM-1219 administration.
Venture capitalists and Wall Street have invested millions of dollars to capitalize on the health care industry's burgeoning demand for information technology. But in New York State, the push to automate the Medicaid enrollment process is being led not by a behemoth IT corporation, but by a tiny not-for-profit: the Hudson Center for Health Equity & Quality (Hudson Center). And 2012 is shaping up to be its breakout year.
› Verified 5 days ago
| Entity Name | Dlp Conemaugh Memorial Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669873881 PECOS PAC ID: 8022238682 Enrollment ID: O20141015000769 |
News Archive
A pioneering professor and investigator at the forefront of genetic services in the United Kingdom and who helped define rare genetic diseases is the 2010 recipient of the March of Dimes/Colonel Harland Sanders Award for lifetime achievement in the field of genetic sciences.
Virtual reality (VR) has potential to revolutionize some aspects of medicine and healthcare. Several medical specialties are already using it to train physicians and assist diagnosis and it also has potential for treatment. A group of cardiologists has now successfully used a VR device to guide the opening up (revascularization) of a chronically blocked right coronary artery.
Cantrell Drug Company today announced amendment of its U.S. Food and Drug Administration (FDA) registration to include the new 503B "compounding outsourcing facility" designation established under the recently passed Drug Quality and Security Act so that it can continue to serve patients nationwide with sterile medications that meet the most exacting quality standards.
Symbiomix Therapeutics, a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women's health infections, today announced results from its Phase 1 clinical program demonstrating that its lead product candidate, SYM-1219, was safe and well tolerated and had predictable pharmacokinetics (PK), and that contraceptive efficacy for birth control pills would not be altered by SYM-1219 administration.
Venture capitalists and Wall Street have invested millions of dollars to capitalize on the health care industry's burgeoning demand for information technology. But in New York State, the push to automate the Medicaid enrollment process is being led not by a behemoth IT corporation, but by a tiny not-for-profit: the Hudson Center for Health Equity & Quality (Hudson Center). And 2012 is shaping up to be its breakout year.
› Verified 5 days ago
| Entity Name | Dlp Conemaugh Miners Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629471768 PECOS PAC ID: 2860612439 Enrollment ID: O20141030001653 |
News Archive
A pioneering professor and investigator at the forefront of genetic services in the United Kingdom and who helped define rare genetic diseases is the 2010 recipient of the March of Dimes/Colonel Harland Sanders Award for lifetime achievement in the field of genetic sciences.
Virtual reality (VR) has potential to revolutionize some aspects of medicine and healthcare. Several medical specialties are already using it to train physicians and assist diagnosis and it also has potential for treatment. A group of cardiologists has now successfully used a VR device to guide the opening up (revascularization) of a chronically blocked right coronary artery.
Cantrell Drug Company today announced amendment of its U.S. Food and Drug Administration (FDA) registration to include the new 503B "compounding outsourcing facility" designation established under the recently passed Drug Quality and Security Act so that it can continue to serve patients nationwide with sterile medications that meet the most exacting quality standards.
Symbiomix Therapeutics, a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women's health infections, today announced results from its Phase 1 clinical program demonstrating that its lead product candidate, SYM-1219, was safe and well tolerated and had predictable pharmacokinetics (PK), and that contraceptive efficacy for birth control pills would not be altered by SYM-1219 administration.
Venture capitalists and Wall Street have invested millions of dollars to capitalize on the health care industry's burgeoning demand for information technology. But in New York State, the push to automate the Medicaid enrollment process is being led not by a behemoth IT corporation, but by a tiny not-for-profit: the Hudson Center for Health Equity & Quality (Hudson Center). And 2012 is shaping up to be its breakout year.
› Verified 5 days ago
| Entity Name | Dlp Conemaugh Miners Medical Center Llc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1184620486 PECOS PAC ID: 2860612439 Enrollment ID: O20200205002348 |
News Archive
A pioneering professor and investigator at the forefront of genetic services in the United Kingdom and who helped define rare genetic diseases is the 2010 recipient of the March of Dimes/Colonel Harland Sanders Award for lifetime achievement in the field of genetic sciences.
Virtual reality (VR) has potential to revolutionize some aspects of medicine and healthcare. Several medical specialties are already using it to train physicians and assist diagnosis and it also has potential for treatment. A group of cardiologists has now successfully used a VR device to guide the opening up (revascularization) of a chronically blocked right coronary artery.
Cantrell Drug Company today announced amendment of its U.S. Food and Drug Administration (FDA) registration to include the new 503B "compounding outsourcing facility" designation established under the recently passed Drug Quality and Security Act so that it can continue to serve patients nationwide with sterile medications that meet the most exacting quality standards.
Symbiomix Therapeutics, a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women's health infections, today announced results from its Phase 1 clinical program demonstrating that its lead product candidate, SYM-1219, was safe and well tolerated and had predictable pharmacokinetics (PK), and that contraceptive efficacy for birth control pills would not be altered by SYM-1219 administration.
Venture capitalists and Wall Street have invested millions of dollars to capitalize on the health care industry's burgeoning demand for information technology. But in New York State, the push to automate the Medicaid enrollment process is being led not by a behemoth IT corporation, but by a tiny not-for-profit: the Hudson Center for Health Equity & Quality (Hudson Center). And 2012 is shaping up to be its breakout year.
› Verified 5 days ago
| Entity Name | Dlp Conemaugh Meyersdale Medical Center, Llc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1659376358 PECOS PAC ID: 0446470041 Enrollment ID: O20201102000630 |
News Archive
A pioneering professor and investigator at the forefront of genetic services in the United Kingdom and who helped define rare genetic diseases is the 2010 recipient of the March of Dimes/Colonel Harland Sanders Award for lifetime achievement in the field of genetic sciences.
Virtual reality (VR) has potential to revolutionize some aspects of medicine and healthcare. Several medical specialties are already using it to train physicians and assist diagnosis and it also has potential for treatment. A group of cardiologists has now successfully used a VR device to guide the opening up (revascularization) of a chronically blocked right coronary artery.
Cantrell Drug Company today announced amendment of its U.S. Food and Drug Administration (FDA) registration to include the new 503B "compounding outsourcing facility" designation established under the recently passed Drug Quality and Security Act so that it can continue to serve patients nationwide with sterile medications that meet the most exacting quality standards.
Symbiomix Therapeutics, a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women's health infections, today announced results from its Phase 1 clinical program demonstrating that its lead product candidate, SYM-1219, was safe and well tolerated and had predictable pharmacokinetics (PK), and that contraceptive efficacy for birth control pills would not be altered by SYM-1219 administration.
Venture capitalists and Wall Street have invested millions of dollars to capitalize on the health care industry's burgeoning demand for information technology. But in New York State, the push to automate the Medicaid enrollment process is being led not by a behemoth IT corporation, but by a tiny not-for-profit: the Hudson Center for Health Equity & Quality (Hudson Center). And 2012 is shaping up to be its breakout year.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher William Follansbee, MD 4401 Penn Ave, Pittsburgh, PA 15224-1334 Ph: (412) 692-8436 | Dr Christopher William Follansbee, MD 4401 Penn Ave, Pittsburgh, PA 15224-1334 Ph: (412) 692-8436 |
News Archive
A pioneering professor and investigator at the forefront of genetic services in the United Kingdom and who helped define rare genetic diseases is the 2010 recipient of the March of Dimes/Colonel Harland Sanders Award for lifetime achievement in the field of genetic sciences.
Virtual reality (VR) has potential to revolutionize some aspects of medicine and healthcare. Several medical specialties are already using it to train physicians and assist diagnosis and it also has potential for treatment. A group of cardiologists has now successfully used a VR device to guide the opening up (revascularization) of a chronically blocked right coronary artery.
Cantrell Drug Company today announced amendment of its U.S. Food and Drug Administration (FDA) registration to include the new 503B "compounding outsourcing facility" designation established under the recently passed Drug Quality and Security Act so that it can continue to serve patients nationwide with sterile medications that meet the most exacting quality standards.
Symbiomix Therapeutics, a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women's health infections, today announced results from its Phase 1 clinical program demonstrating that its lead product candidate, SYM-1219, was safe and well tolerated and had predictable pharmacokinetics (PK), and that contraceptive efficacy for birth control pills would not be altered by SYM-1219 administration.
Venture capitalists and Wall Street have invested millions of dollars to capitalize on the health care industry's burgeoning demand for information technology. But in New York State, the push to automate the Medicaid enrollment process is being led not by a behemoth IT corporation, but by a tiny not-for-profit: the Hudson Center for Health Equity & Quality (Hudson Center). And 2012 is shaping up to be its breakout year.
› Verified 5 days ago
Howard Ira Topol, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 969 Greentree Rd Ste 100, Pittsburgh, PA 15220 Phone: 412-922-5250 Fax: 411-920-8162 | |
Allison Williams, Pediatrics Medicare: Medicare Enrolled Practice Location: 4401 Penn Ave, Aob Suite 5400, Pittsburgh, PA 15224 Phone: 412-692-5285 | |
Christin Lawler Deal, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4401 Penn Ave, Pittsburgh, PA 15224 Phone: 404-226-4169 | |
Mr. Jacob Richard White, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 88 Fort Couch Rd Ste 100, Pittsburgh, PA 15241 Phone: 412-831-1114 | |
Dr. Domenic Joseph Filingeri, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 4401 Penn Ave, Endocrinology And Diabetes Clinic, 3rd Floor, Pittsburgh, PA 15224 Phone: 412-692-5170 | |
Kyle Pohl, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 3550 Terrace Street, Scaife Hall 6th Floor, Pittsburgh, PA 15261 Phone: 907-729-1900 |